Brian Mi, president of IQVIA Greater China, shares IQVIA’s leadership position in China in both the commercial and R&D space, building on both IMS Health and Quintiles’ market positioning in China prior to the merger; the CORETM components of IQVIA’s competitive advantage and their transformation into a Human Data Science company; and his personal excitement to be part of IQVIA’s mission to transform the way innovative medicines are developed and delivered to patients.
We want to leverage data, information and technology to transform the way medicines are developed so that they can be delivered to patients more quickly and effectively
